OncWeekly Content Page - Page 38

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

DS-8201a in HER2-Positive NSCLC: Results from DESTINY-Lung01 Phase 2 Trial

Apr 20, 2023

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

KEYNOTE-799 Phase 2 Trial: Pembrolizumab Combining Chemotherapy and Radiotherapy for Stage III NSCLC

Apr 20, 2023

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

Durvalumab Following Chemo Radiation in Unresectable Stage III NSCLC: Phase 2 PACIFIC 6 Trial

Apr 20, 2023

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

Phase 2 ALTA-2 Trial: Efficacy of brigAtinib in NSCLC Patients Resistant to Alectinib and Ceritinib

Apr 20, 2023

Advertisement

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

Atezolizumab in the Treatment of Resectable NSCLC: Phase 2 LCMC3 Trial

Apr 20, 2023

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

Combining Pembrolizumab and Ipilimumab in NSCLC Treatment: KEYNOTE-598 Phase 3 Study

Apr 20, 2023

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

IPSOS Clinical Trial: Atezolizumab in Non-Small Cell Lung Cancer Treatment Naïve Participants

Apr 20, 2023

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

Adjuvant Therapy with Canakinumab for Completely Resected NSCLC: CANOPY-A Phase 3 Trial

Apr 20, 2023

Previous
1
…
36
37
38
39
40
Next

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Advertisement